Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Uterine Neoplasms × larotrectinib × Clear all

Sponsor

Conditions

Central Nervous System Neoplasms 3 Wilms Tumor 2 Sarcoma 2 Rhabdomyosarcoma 2 Rhabdoid Tumor 2 Osteosarcoma 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Neuroblastoma 2 Medulloblastoma 2 Lymphoma, Non-Hodgkin 2 Histiocytosis, Langerhans-Cell 2 Hepatoblastoma 2 Glioma 2 Ependymoma 2 Xanthogranuloma, Juvenile 1 Sarcoma, Ewing 1 Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion 1 Histiocytic Sarcoma 1

Interventions

Paclitaxel 6 Radiotherapy 2 Pemetrexed 2 Carboplatin 2 Brachytherapy 2 tucatinib 1 seribantumab 1 osimertinib 1 gedatolisib 1 fosaprepitant 1 fluciclovine F-18 1 cobimetinib 1 atezolizumab 1 alovudine 1 Trastuzumab 1 Therapeutics 1 TP protocol 1 Saline Solution 1 Radiation 1 Protons 1 Palliative Care 1 Nivolumab 1 Letrozole 1 Immunoglobulin G 1 Imatinib Mesylate 1 Ifosfamide 1 Gemcitabine 1 Fulvestrant 1 FANG vaccine 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡